Plaintiffs in N.J. Tasigna Injury Cases Seek Consolidation for Pretrial Proceedings



DOCUMENTS
  • Application


TRENTON, N.J. — Plaintiffs in lawsuits targeting Novartis Pharmaceuticals Corp.’s leukemia drug Tasigna have asked the New Jersey Supreme Court to consolidate the actions before one judge for pretrial proceedings as part of a state multi-county litigation.

On Feb. 9, the Acting Administrative Director for New Jersey state courts notified the bar of the request to transfer the Tasigna cases pending in different counties throughout the state to Judge Rachelle of the Bergen County Superior Court.

Tasigna (nilotinib) was approved by the FDA in 2007 and is part of a class of drugs known as kinase inhibitors, which are prescribed …

FIRM NAMES
  • Parker Waichman LLP





UPCOMING CONFERENCES




HarrisMartin’s Webinar Series: Acetaminophen ASD/ADHD Product Liability Litigation

October 21, 2022

MORE DETAILS



HarrisMartin's MDL Conference: The Current Mass Tort Landscape - Best Management Practices & Updates on Key Litigation

September 28, 2022 - St. Louis, MO
Four Seasons Hotel, St. Louis

MORE DETAILS